Xenetic Biosciences Inc (XBIO) — Capital Reinvestment Ratio

Latest as of December 2017: 0.00x

Xenetic Biosciences Inc (XBIO) has a Capital Reinvestment Ratio of 0.00x as of December 2017, meaning it reinvests 0% of its operating cash flow ($4.84 Million) in capital expenditures ($9.00K). See Xenetic Biosciences Inc (XBIO) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.84 Million
USD

Capital Expenditures

$9.00K
USD

Data as of

Dec 2017
Most recent filing

Xenetic Biosciences Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks Xenetic Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. Check Xenetic Biosciences Inc (XBIO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Xenetic Biosciences Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for Xenetic Biosciences Inc from 2017 to 2017. For live market cap and broader valuation context, see market cap of Xenetic Biosciences Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2017 0.01x $1.49 Million $9.26K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow